Collplant Biotechnologies LtdNASDAQ:CLGN
- LAST PRICE4.2576
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.3000/ 3
- Ask / Lots6.8800/ 2
- Open / Previous Close--- / 4.2576
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CLGN |
|---|---|---|
| 09:32 ET | 101 | 4.15 |
| 09:48 ET | 252 | 4.15 |
| 10:45 ET | 760 | 4.2 |
| 11:05 ET | 1245 | 4.24 |
| 12:19 ET | 364 | 4.24 |
| 02:48 ET | 700 | 4.3 |
| 03:19 ET | 1008 | 4.3 |
| 03:55 ET | 1000 | 4.2576 |
Nov 12, 2024
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION, from 7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Collplant Biotechnologies Ltd | 47.4M | -2.8x | --- |
Affimed NV | 39.9M | -0.6x | --- |
Curis Inc | 33.5M | -0.5x | --- |
LAVA Therapeutics NV | 42.1M | -1.8x | --- |
DURECT Corp | 31.3M | -1.7x | --- |
Kezar Life Sciences Inc | 54.7M | -0.6x | --- |
Company Information
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Contact Information
- Headquarters
- 4 Oppenheimer Street, P.O. Box 4132REHOVOT, Israel 7670104
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Roger Pomerantz
- Chief Executive Officer
- Yehiel Tal
- Deputy Chief Executive Officer, Chief Financial Officer
- Eran Rotem
- Vice President - Operations
- Ilana Belzer
- Vice President - Human Resources
- Hadas Dreiher Horowitz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $47.4M |
|---|---|
Revenue (TTM) | $689.0K |
Shares Outstanding | 11.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $-1.53 |
Book Value | $2.47 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 68.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,671.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
